Annual Long Term Debt
$104.77 M
+$50.77 M+94.01%
December 31, 2023
Summary
- As of February 7, 2025, LXRX annual long term debt is $104.77 million, with the most recent change of +$50.77 million (+94.01%) on December 31, 2023.
- During the last 3 years, LXRX annual long term debt has risen by +$104.16 million (+17047.79%).
- LXRX annual long term debt is now -57.04% below its all-time high of $243.89 million, reached on December 31, 2018.
Performance
LXRX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$99.89 M
+$396.00 K+0.40%
September 30, 2024
Summary
- As of February 7, 2025, LXRX quarterly long term debt is $99.89 million, with the most recent change of +$396.00 thousand (+0.40%) on September 30, 2024.
- Over the past year, LXRX quarterly long term debt has dropped by -$5.06 million (-4.82%).
- LXRX quarterly long term debt is now -59.05% below its all-time high of $243.95 million, reached on June 30, 2019.
Performance
LXRX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
LXRX Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +94.0% | -4.8% |
| 3 y3 years | +10000.0% | +241.8% |
| 5 y5 years | -57.0% | -57.3% |
LXRX Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +8704.5% | -4.8% | +8294.5% |
| 5 y | 5-year | -55.3% | >+9999.0% | -57.5% | >+9999.0% |
| alltime | all time | -57.0% | >+9999.0% | -59.0% | >+9999.0% |
Lexicon Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $99.89 M(+0.4%) |
| Jun 2024 | - | $99.50 M(-5.2%) |
| Mar 2024 | - | $104.95 M(+0.2%) |
| Dec 2023 | $104.77 M(+94.0%) | $104.77 M(+0.1%) |
| Sep 2023 | - | $104.71 M(+0.4%) |
| Jun 2023 | - | $104.25 M(+92.0%) |
| Mar 2023 | - | $54.30 M(+0.5%) |
| Dec 2022 | $54.00 M(+4438.1%) | $54.00 M(+84.8%) |
| Sep 2022 | - | $29.22 M(+18.6%) |
| Jun 2022 | - | $24.63 M(+0.2%) |
| Mar 2022 | - | $24.57 M(+1965.1%) |
| Dec 2021 | $1.19 M(+94.8%) | $1.19 M(-19.6%) |
| Sep 2021 | - | $1.48 M(+142.4%) |
| Dec 2020 | $611.00 K(-99.7%) | $611.00 K(-94.7%) |
| Sep 2020 | - | $11.63 M(-95.0%) |
| Jun 2020 | - | $234.81 M(+0.1%) |
| Mar 2020 | - | $234.49 M(+0.1%) |
| Dec 2019 | $234.17 M(-4.0%) | $234.17 M(+0.1%) |
| Sep 2019 | - | $233.84 M(-4.1%) |
| Jun 2019 | - | $243.95 M(+0.0%) |
| Mar 2019 | - | $243.91 M(+0.0%) |
| Dec 2018 | $243.89 M(+5.3%) | $243.89 M(+0.0%) |
| Sep 2018 | - | $243.83 M(+5.0%) |
| Jun 2018 | - | $232.20 M(+0.1%) |
| Mar 2018 | - | $231.88 M(+0.1%) |
| Dec 2017 | $231.58 M(+171.9%) | $231.58 M(+170.8%) |
| Sep 2017 | - | $85.51 M(+0.2%) |
| Jun 2017 | - | $85.38 M(+0.1%) |
| Mar 2017 | - | $85.27 M(+0.1%) |
| Dec 2016 | $85.17 M(-15.6%) | $85.17 M(+0.2%) |
| Sep 2016 | - | $85.04 M(+0.2%) |
| Jun 2016 | - | $84.91 M(-15.6%) |
| Mar 2016 | - | $100.55 M(-0.4%) |
| Dec 2015 | $100.96 M(+15.4%) | $100.96 M(+15.4%) |
| Sep 2015 | - | $87.50 M(0.0%) |
| Jun 2015 | - | $87.50 M(0.0%) |
| Mar 2015 | - | $87.50 M(0.0%) |
| Dec 2014 | $87.50 M(+333.9%) | $87.50 M(+354.4%) |
| Jun 2014 | - | $19.25 M(-2.3%) |
| Mar 2014 | - | $19.71 M(-2.3%) |
| Dec 2013 | $20.17 M(-7.8%) | $20.17 M(-2.1%) |
| Sep 2013 | - | $20.61 M(-4.0%) |
| Mar 2013 | - | $21.46 M(-1.9%) |
| Dec 2012 | $21.88 M | $21.88 M(-1.8%) |
| Sep 2012 | - | $22.28 M(-1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $22.68 M(-1.7%) |
| Mar 2012 | - | $23.06 M(-1.7%) |
| Dec 2011 | $23.45 M(-14.2%) | $23.45 M(-1.6%) |
| Sep 2011 | - | $23.83 M(-1.5%) |
| Jun 2011 | - | $24.19 M(-10.6%) |
| Mar 2011 | - | $27.04 M(-1.1%) |
| Dec 2010 | $27.34 M(-4.0%) | $27.34 M(-1.1%) |
| Sep 2010 | - | $27.64 M(-1.0%) |
| Jun 2010 | - | $27.92 M(-1.0%) |
| Mar 2010 | - | $28.20 M(-1.0%) |
| Dec 2009 | $28.48 M(-3.5%) | $28.48 M(-0.9%) |
| Sep 2009 | - | $28.75 M(-56.4%) |
| Jun 2009 | - | $65.97 M(+50.1%) |
| Mar 2009 | - | $43.94 M(+48.8%) |
| Dec 2008 | $29.53 M(-3.2%) | $29.53 M(-0.8%) |
| Sep 2008 | - | $29.78 M(-0.8%) |
| Jun 2008 | - | $30.02 M(-0.8%) |
| Mar 2008 | - | $30.25 M(-0.8%) |
| Dec 2007 | $30.49 M(-2.8%) | $30.49 M(-0.7%) |
| Sep 2007 | - | $30.72 M(-0.7%) |
| Jun 2007 | - | $30.94 M(-0.7%) |
| Mar 2007 | - | $31.16 M(-0.7%) |
| Dec 2006 | $31.37 M(-2.5%) | $31.37 M(-0.7%) |
| Sep 2006 | - | $31.58 M(-0.6%) |
| Jun 2006 | - | $31.79 M(-0.6%) |
| Mar 2006 | - | $31.98 M(-0.6%) |
| Dec 2005 | $32.19 M(-2.3%) | $32.19 M(-0.6%) |
| Sep 2005 | - | $32.38 M(-0.6%) |
| Jun 2005 | - | $32.57 M(-0.5%) |
| Mar 2005 | - | $32.75 M(-0.6%) |
| Dec 2004 | $32.94 M(-41.5%) | $32.94 M(-11.3%) |
| Sep 2004 | - | $37.12 M(-0.5%) |
| Jun 2004 | - | $37.29 M(-33.8%) |
| Mar 2004 | - | $56.34 M(0.0%) |
| Dec 2003 | $56.34 M(+1308.6%) | $56.34 M(+1308.6%) |
| Sep 2003 | - | $4.00 M(0.0%) |
| Jun 2003 | - | $4.00 M(0.0%) |
| Mar 2003 | - | $4.00 M(0.0%) |
| Dec 2002 | $4.00 M(+118.1%) | $4.00 M(+6691.2%) |
| Sep 2001 | - | $58.90 K(-96.3%) |
| Mar 2001 | - | $1.58 M(-13.9%) |
| Dec 2000 | $1.83 M(-48.7%) | $1.83 M(-17.0%) |
| Sep 2000 | - | $2.21 M(-8.7%) |
| Jun 2000 | - | $2.42 M(-26.8%) |
| Mar 2000 | - | $3.31 M |
| Dec 1999 | $3.58 M | - |
FAQ
- What is Lexicon Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals annual long term debt year-on-year change?
- What is Lexicon Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals quarterly long term debt year-on-year change?
What is Lexicon Pharmaceuticals annual long term debt?
The current annual long term debt of LXRX is $104.77 M
What is the all time high annual long term debt for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high annual long term debt is $243.89 M
What is Lexicon Pharmaceuticals annual long term debt year-on-year change?
Over the past year, LXRX annual long term debt has changed by +$50.77 M (+94.01%)
What is Lexicon Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of LXRX is $99.89 M
What is the all time high quarterly long term debt for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high quarterly long term debt is $243.95 M
What is Lexicon Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, LXRX quarterly long term debt has changed by -$5.06 M (-4.82%)